Bezlotoxumab for Preventing Recurrent Clostridioides Difficile Infection: A Narrative Review From Pathophysiology to Clinical Studies

Infect Dis Ther. 2020 Jul 6. doi: 10.1007/s40121-020-00314-5.

Daniele Roberto Giacobbe, Silvia Dettori, Stefano Di Bella, Antonio Vena, Guido Granata, Roberto Luzzati, Nicola Petrosillo, Matteo Bassetti